Cargando…
Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
Chronic infection with hepatitis C virus (HCV) affects an estimated 0.1%–2% of the pediatric population in the United States. While the clinical course in young children is indolent, adolescents who contract HCV have a disease course similar to adults, with a 26-fold increased risk of chronic liver...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071628/ https://www.ncbi.nlm.nih.gov/pubmed/30104913 http://dx.doi.org/10.2147/AHMT.S147896 |